triamcinolone acetonide has been researched along with Musculoskeletal Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aazami, HA; Bodick, N; Conaghan, PG; Hauben, J; Johnson, JR; Kivitz, AJ; Kraus, VB; Lufkin, J; Mehra, P | 1 |
| Ballal, R; Bodick, N; Bolognese, J; Clayman, M; Hunter, D; Kumar, A; Lufkin, J; Schoonmaker, C; Willwerth, C | 1 |
2 trial(s) available for triamcinolone acetonide and Musculoskeletal Pain
| Article | Year |
|---|---|
Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
Topics: Anti-Inflammatory Agents; Crystallization; Delayed-Action Preparations; Female; Humans; Injections, Intra-Articular; Male; Microspheres; Middle Aged; Musculoskeletal Pain; Osteoarthritis, Knee; Synovial Fluid; Treatment Outcome; Triamcinolone Acetonide | 2018 |
An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
Topics: Analgesics; Anti-Inflammatory Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intra-Articular; Male; Middle Aged; Musculoskeletal Pain; Osteoarthritis, Knee; Treatment Outcome; Triamcinolone Acetonide | 2015 |